ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 990,11
-0,51%
Dow Jones
42 299,70
-0,37%
DAX
22 678,74
-0,74%
Brent Oil
73,435
0,05%
Bitcoin
86 845,76
-0,42%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. ReShape Lifesciences Inc (RSLS) Cours

ReShape Lifesciences Inc

ReShape Lifesciences Inc (RSLS)

NASDAQ
0,4405
-0,0318
(-6,73%)
Fermé 28 Mars 9:00PM
Retardé de 15 minutes
0,449
0,0085
(1,93%)
Après les heures de négociation: 12:00AM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,449
Prix Achat
0,45
Prix Vente
0,49
Volume échangé
385 485
0,4397 Fourchette du Jour 0,4812
0,4403 Plage de 52 semaines 29,00
Cap du marché
319,993k
Clôture Veille
0,4723
Ouverture
0,46
Dernière Transaction
12
@
0.4697
Dernière heure de transaction
Volume financier
US$ 176 487
VWAP
0,457831
Volume moyen (3 m)
1 250 785
Actions en circulation
712 680
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,03
Bénéfice par action (BPA)
-15,98
Chiffre d'affairess
8,68M
Bénéfice net
-11,39M

À propos de ReShape Lifesciences Inc

Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. Show more

Secteur
Surgical,med Instr,apparatus
Industrie
Surgical,med Instr,apparatus
Site Web
www.reshapelifesciences.com
Siège social
Wilmington, Delaware, USA
Fondé
-
ReShape Lifesciences Inc est coté dans le secteur Surgical,med Instr,apparatus de la NASDAQ avec le ticker RSLS. Le dernier cours de clôture d'ReShape Lifesciences était de US$0,47. Au cours de la dernière année, les actions de ReShape Lifesciences ont été négociées dans une fourchette de prix de US$ 0,4403 à US$ 29,00.

ReShape Lifesciences compte actuellement 712 680 actions en circulation. La capitalisation boursière d'ReShape Lifesciences est de US$336 598,76 . ReShape Lifesciences a un ratio cours/bénéfice (ratio PE) de -0.03.

RSLS Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report
Edgar (US Regulatory)
20 Mars 2025
RSLS (-6,73%)

Form DEF 14A - Other definitive proxy statements
Edgar (US Regulatory)
14 Mars 2025
RSLS (-6,73%)

Form PRER14A - Preliminary Proxy Soliciting materials
Edgar (US Regulatory)
13 Mars 2025
RSLS (-6,73%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
24 Février 2025
RSLS (-6,73%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
24 Février 2025
RSLS (-6,73%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
21 Février 2025
RSLS (-6,73%)

Form 8-K - Current report
Edgar (US Regulatory)
20 Février 2025
RSLS (-6,73%)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Edgar (US Regulatory)
18 Février 2025
RSLS (-6,73%)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.171-27.58064516130.620.74990.44035765340.54135915CS
4-0.661-59.54954954951.111.280.44035764210.81444509CS
12-4.041-904.495.190.440312507851.26451119CS
26-5.181-92.02486678515.637.20.44036168691.59737272CS
52-10.455-95.882245047710.904290.4403204027412.11072207CS
156-4059.551-99.9889408867406044660.44031597372111.2147156CS
260-752.681-99.9403821385753.13275500.440314136183020.90180921CS

RSLS - Frequently Asked Questions (FAQ)

What is the current ReShape Lifesciences share price?
The current share price of ReShape Lifesciences is US$ 0,449
How many ReShape Lifesciences shares are in issue?
ReShape Lifesciences has 712 680 shares in issue
What is the market cap of ReShape Lifesciences?
The market capitalisation of ReShape Lifesciences is USD 336,6k
What is the 1 year trading range for ReShape Lifesciences share price?
ReShape Lifesciences has traded in the range of US$ 0,4403 to US$ 29,00 during the past year
What is the PE ratio of ReShape Lifesciences?
The price to earnings ratio of ReShape Lifesciences is -0,03
What is the cash to sales ratio of ReShape Lifesciences?
The cash to sales ratio of ReShape Lifesciences is 0,04
What is the reporting currency for ReShape Lifesciences?
ReShape Lifesciences reports financial results in USD
What is the latest annual turnover for ReShape Lifesciences?
The latest annual turnover of ReShape Lifesciences is USD 8,68M
What is the latest annual profit for ReShape Lifesciences?
The latest annual profit of ReShape Lifesciences is USD -11,39M
What is the registered address of ReShape Lifesciences?
The registered address for ReShape Lifesciences is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the ReShape Lifesciences website address?
The website address for ReShape Lifesciences is www.reshapelifesciences.com
Which industry sector does ReShape Lifesciences operate in?
ReShape Lifesciences operates in the SURGICAL,MED INSTR,APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
GATEMarblegate Acquisition Corporation
US$ 57,96
(256,46%)
77,14k
LYTLytus Technologies Holdings PTV Ltd
US$ 0,11725
(88,20%)
1,01B
DRCTDirect Digital Holdings Inc
US$ 1,33
(71,61%)
24,25M
GTECGreenland Technologies Holding Corporation
US$ 2,1701
(65,66%)
78,57M
NKTXNkarta Inc
US$ 1,975
(44,16%)
27,28M
TDTHTrident Digital Tech Holdings Ltd
US$ 0,5905
(-60,90%)
45,25M
LGMKLogicMark Inc
US$ 0,0505
(-45,29%)
54,05M
EQEquillium Inc
US$ 0,4603
(-39,27%)
1,34M
NXUNXU Inc
US$ 0,1688
(-36,28%)
10,76M
SAIHSAIHEAT Ltd
US$ 5,72
(-33,40%)
53,5k
LYTLytus Technologies Holdings PTV Ltd
US$ 0,11725
(88,20%)
1,01B
DMNDamon Inc
US$ 0,0447
(14,91%)
432,5M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 10,62
(0,66%)
286,67M
NVDANVIDIA Corporation
US$ 111,43
(-2,05%)
236,84M
OCEAOcean Biomedical Inc
US$ 0,074
(-11,59%)
220,93M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
RSLS
ReShape Lifesciences
Delayed Upgrade Clock
ADVFN Logo
France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés

Supprimer les publicités

Inscrivez-vous pour une expérience sans publicité

Aucune publicité

Essayez maintenant

Conserver les annonces